ArticleHaematologica2020

CRISPR/Cas9-mediated gene deletion efficiently retards the progression of Philadelphia-positive acute lymphoblastic leukemia in a p210 BCR-ABL1

Yu-Ting Tan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.